Asmerom Sengal (@atsengal) 's Twitter Profile
Asmerom Sengal

@atsengal

Molecular Oncology/Pathology Gynaecological Oncology

ID: 1248062969147084800

calendar_today09-04-2020 01:39:58

25 Tweet

28 Takipçi

49 Takip Edilen

Asmerom Sengal (@atsengal) 's Twitter Profile Photo

This is our recent interesting article demonstrating the predictive value of FGFR2 isoforms to LNG-IUD treatment in atypical hyperplasia and endometrial cancer. mdpi.com/2072-6694/13/7…

ANZGOG (@anzgog) 's Twitter Profile Photo

Next up is Dr Asmeron Sengal from A/Prof PamPollock 's group presenting on the role of FGFR2 dysregulation (isoform switching) in endometrial cancer & the efficacy of FGFR inhibition in endometrial cancer patient derived models with FGFR2c splice isoform expression #ANZGOG2022ASM

Asmerom Sengal (@atsengal) 's Twitter Profile Photo

Our paper has recently been published in the Journal of Pathology: Clinical Research. In this article, we have demonstrated the role of the two #FGFR2 splice isoforms (FGFR2b and FGFR2c) in stratifying #endometrial #cancer. onlinelibrary.wiley.com/doi/10.1002/cj…

Sirak Bahlbi (@sirakbahlbi) 's Twitter Profile Photo

If #Eritrea can produce a world beating athletes in sports that require heavy investment and long term strategy under tremendous amount of existential national threat; imagine the possibilities if it were free to reach its potential Biniam Girmay #EritreaPrevails

If #Eritrea can produce a world beating athletes in sports that require heavy investment and long term strategy under tremendous amount of existential national threat; imagine the possibilities if it were free to reach its potential <a href="/GrmayeBiniam/">Biniam Girmay</a> #EritreaPrevails
Asmerom Sengal (@atsengal) 's Twitter Profile Photo

Delighted to be one of the Cure Cancer ECR grant scheme 2023 awardee. Thank you #CureCancer for the generous support to fund cutting edge research. x.com/CureCancerAu/s…

Asmerom Sengal (@atsengal) 's Twitter Profile Photo

Our recent paper submitted in #natureprecisiononcology coming out in preprint. #FGFR2c as novel target therapy in #endometrialcancer.

Asmerom Sengal (@atsengal) 's Twitter Profile Photo

Excited to join the PLOS One Editorial Board, an #OpenScience journal publishing trusted research in over 200 subject areas across science, engineering, medicine and the related social sciences and humanities.

Excited to join the <a href="/PLOSONE/">PLOS One</a> Editorial Board, an #OpenScience journal publishing trusted research in over 200 subject areas across science, engineering, medicine and the related social sciences and humanities.
Asmerom Sengal (@atsengal) 's Twitter Profile Photo

#Endometrialcancer is an exception with a trend of remarkable increase in both incidence and mortality. It's less funded and researched. Tomorrow at 12:30PM local time a "Lunch and Learn" session will be held hosted by #CureCancer to increase awareness curecancer.com.au/lunch-and-lear…

Asmerom Sengal (@atsengal) 's Twitter Profile Photo

Happy to share our recent paper which was published in Nature Precision Oncology last week. The study opens a new avenue of personalised treatment options for endometrial cancer patients. nature.com/articles/s4169…